NCT02879786
- Conditions
- Communication Disorders, Dyslexia, Language Disorders, +9 more
- Locations
-
- Centre de Référence pour les Troubles des Apprentissages - Hôpital d'Enfants - CHU de Nancy Vandœuvre-lès-Nancy, France
Clinical trial condition
Dyslexia
Explore clinical trials studying Dyslexia. Study availability and eligibility vary by location and protocol.
94 public trials
16 recruiting studies
Dyslexia trial results
NCT02872870
- Conditions
- Aphasia, Communication Disorders, Dyslexia, +12 more
- Locations
-
- Université catholique de Louvain (IPSY) Louvain-la-Neuve, Belgium
- Hôpital Saint Vincent de Paul (GHICL) Lille, France
- Université de Lille 3 Charles de Gaulle (URECA) Villeneuve-d'Ascq, France
NCT02429739
- Conditions
- Communication Disorders, Dyslexia, Language Disorders, +9 more
- Locations
-
- Sorlandet Hospital Arendal, Aust-Agder, Norway
NCT02422732
- Conditions
- Communication Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslexia, +25 more
- Locations
-
- CHU Toulouse Toulouse, France
NCT01012778
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +12 more
- Locations
-
- MDKV Schools Najībābād, Uttar Pradesh, India
NCT00065832
- Conditions
- Communication Disorders, Dyslexia, Language Disorders, +9 more
- Locations
-
Not specified
Completed
Reading Disability in Children With NF1
NCT02397967
- Conditions
- Communication Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslexia, +25 more
- Locations
-
- Hopital femme-mére-enfant, Hospices civils de lyon Lyon, France
- Hôpital Gui de Chauliac Montpellier, France
- CHU Hôtel-Dieu, Clinic of Dermatology Nantes, France
- AP-HP Hopital Armand Trousseau Paris, France
NCT02316873
- Conditions
- Communication Disorders, Dyslexia, Language Disorders, +10 more
- Locations
-
Not specified
NCT00064805
- Conditions
- Brain Diseases, Brain Injuries, Cardiovascular Diseases, +22 more
- Locations
-
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
Completed
Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia
NCT00607919
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +12 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Irvine, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palo Alto, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Haven, Connecticut, United States